StockClub

REGN

REGNRegeneron Pharmaceuticals, Inc.$ --
Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

REGN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
3,605M USD
YoY +19.0%
Operating Income
643M USD
YoY +8.7%
Net Income
727M USD
YoY -10.1%
EPS
6.99$
YoY -7.8%

Revenue

$3.6B
FY2024 Q2$6.7B
$6.7B
Q2
FY2024 Q3$10.4B
$10.4B
Q3
FY2024 Q4$14.2B
$14.2B
Q4
FY2025 Q1$3B
$3B
Q1
FY2025 Q2$6.7B
$6.7B
Q2
FY2025 Q3$10.5B
$10.5B
Q3
FY2025 Q4$14.3B
$14.3B
Q4
FY2026 Q1$3.6B
$3.6B
Q1
Actual
+$576.7M (+19.0%)

Net Income

$727.2M
FY2024 Q2$2.2B
$2.2B
Q2
FY2024 Q3$3.5B
$3.5B
Q3
FY2024 Q4$4.4B
$4.4B
Q4
FY2025 Q1$808.7M
$808.7M
Q1
FY2025 Q2$2.2B
$2.2B
Q2
FY2025 Q3$3.7B
$3.7B
Q3
FY2025 Q4$4.5B
$4.5B
Q4
FY2026 Q1$727.2M
$727.2M
Q1
Actual
$-81.5M (-10.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$8.5B
Est:$8.5B
FY2020BEAT
$8.5B
FY2021BEAT
Actual:$16.1B
Est:$15.7B
FY2021BEAT
$16.1B
FY2022BEAT
Actual:$12.2B
Est:$11.9B
FY2022BEAT
$12.2B
FY2023MISS
Actual:$13.1B
Est:$13.5B
FY2023MISS
$13.1B
FY2024BEAT
Actual:$14.2B
Est:$14.2B
FY2024BEAT
$14.2B
FY2025BEAT
Actual:$14.3B
Est:$14.3B
FY2025BEAT
$14.3B

Analyst Estimates